Michael Gelband’s Stepan Co SCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,559
Closed -$328K 2003
2026
Q1
$328K Buy
+6,559
New +$351K ﹤0.01% 1297
2025
Q2
Sell
-26,710
Closed -$1.47M 1918
2025
Q1
$1.47M Buy
26,710
+18,580
+229% +$1.13M 0.01% 811
2024
Q4
$526K Sell
8,130
-23,484
-74% -$1.74M ﹤0.01% 1142
2024
Q3
$2.44M Buy
+31,614
New +$2.51M 0.01% 653
2023
Q4
Sell
-4,627
Closed -$347K 1984
2023
Q3
$347K Buy
+4,627
New +$404K ﹤0.01% 1374
2021
Q3
Sell
-7,720
Closed -$928K 2570
2021
Q2
$928K Buy
+7,720
New +$1.01M 0.01% 1054
2020
Q3
Sell
-11,491
Closed -$1.12M 2176
2020
Q2
$1.12M Buy
+11,491
New +$1.08M 0.03% 687

Other funds holding SCL

Michael Gelband's SCL Position: Q2 2026 in Review

Michael Gelband sold out of Stepan Co (SCL) in Q2 2026, closing a stake of 6,559 shares — an estimated $328K sold.

Michael Gelband first reported a position in SCL in Q2 2020 and held it in 7 quarters. The position peaked at $2.44M in Q3 2024. 228 funds tracked by Wall St. Rank hold SCL as of Q2 2026.

  • Michael Gelband reported no remaining Stepan Co position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 6,559 Stepan Co shares in Q2 2026, an estimated $328K.
  • Michael Gelband first reported a position in Stepan Co in Q2 2020 and held it in 7 quarters.
  • Michael Gelband's Stepan Co position peaked at $2.44M in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Stepan Co as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.